Company intelligence / Profile preview
San Rocco Therapeutics
Tampa, Florida, United Statessanroccotherapeutics.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
San Rocco Therapeutics has developed a gene therapy for Sickle Cell Disease and Beta Thalassemia using a lentiviral vector carrying the natural wild-type beta globin gene. The company claims superior safety compared to competitors due to lack of clonal dominance or leukemia in treated patients. The therapy aims for affordability and broad access, with plans for further clinical trials in the U.S. and Europe by late 2025[3][4][6].
- Therapeutic areas
- Hematology
- Modalities
- Gene therapy
- Industry
- Biotech
02
Drug pipeline
9 assets8 more assets in the full pipeline.
03
Partnerships
Collaborations with Memorial Sloan Kettering Cancer CenterCornell UniversityNational Institutes of Healthpast collaborations include St. Jude Children’s Research HospitalUniversity of MilanUniversity of MinnesotaBoston Children’s Hospital among others[1][5].
Beyond the preview
Go deeper on San Rocco Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on San Rocco Therapeutics.